Weekly rapamycin did not enhance exercise gains in older adults and may have limited overall functional improvements.
“Researchers measured chair-stand performance as the main outcome, along with other measures of physical function and quality of life, C-reactive protein (CRP, a marker of inflammation), epigenetic age measures (estimates of biological age based on chemical tags on DNA), routine safety blood tests, and adverse events.”